logo
Plus   Neg
Share
Email

Sienna Biopharma To File For Bankruptcy

Sienna Biopharmaceuticals Inc. (SNNA) said Tuesday that it has elected to file a voluntary petition to allow restructuring under Chapter 11 of the Bankruptcy Code.

"The protections afforded by Chapter 11 provide for an orderly restructuring process as well as additional time to pursue financial and strategic alternatives," said Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna.

In Tuesday Pre-market trade, SNNA is trading at $0.3788, down $0.29 or 43.74 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Transportation says it received lesser number of complaints from consumers about airline services in August. In August, DOT received 1,712 complaints about airline service from consumers, down 1.0% from the total of 1,730 filed in August 2018 and down 8.7% from the 1,875 received... Shares of Netflix Inc. (NFLX) jumped 7% in extended trading session Wednesday after the online-video streaming giant said it added more subscribers in the third quarter after a disappointing previous quarter. The company's third-quarter earnings topped Wall Street estimates, as revenues surged 31%. Netflix... Alcoa Corp. (AA), the largest producer of aluminum in the US, Wednesday posted a wider-than-expected loss for the third quarter, reflecting a drop in revenues as well as one-time charges related to two smelters in Spain. The company also announced a "portfolio review" of its smelting and refining capacity...
RELATED NEWS
Follow RTT
>